The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

被引:785
作者
Sheehy, AM
Gaddis, NC
Malim, MH [1 ]
机构
[1] Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England
[2] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA
基金
美国国家科学基金会; 英国医学研究理事会;
关键词
D O I
10.1038/nm945
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human protein apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3G (APOBEC3G), also known as CEM-15, mediates a newly described form of innate resistance to retroviral infection by catalyzing the deamination of deoxycytidine to deoxyuridine in viral cDNA replication intermediates. Because DNA deamination takes place after virus entry into target cells, APOBEC3G function is dependent on its association with the viral nucleoprotein complexes that synthesize cDNA and must therefore be incorporated into virions as they assemble in infected cells. Here we show that the HIV-1 virion infectivity factor (Vif) protein protects the virus from APOBEC3G-mediated inactivation by preventing its incorporation into progeny virions, thus allowing the ensuing infection to proceed without DNA deamination. In addition to helping exclude APOBEC3G from nascent virions, Vif also removes APOBEC3G from virus-producing cells by inducing its ubiquitination and subsequent degradation by the proteasome. Our findings indicate that pharmacologic strategies aimed at stabilizing APOBEC3G in HIV-1 infected cells should be explored as potential HIV/AIDS therapeutics.
引用
收藏
页码:1404 / 1407
页数:4
相关论文
共 25 条
  • [11] CYSTEINE RESIDUES IN THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE ESSENTIAL FOR VIRAL INFECTIVITY
    MA, XY
    SOVA, P
    CHAO, W
    VOLSKY, DJ
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (03) : 1714 - 1720
  • [12] Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
    Mangeat, B
    Turelli, P
    Caron, G
    Friedli, M
    Perrin, L
    Trono, D
    [J]. NATURE, 2003, 424 (6944) : 99 - 103
  • [13] A novel human WD protein, h-βTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif
    Margottin, F
    Bour, SP
    Durand, H
    Selig, L
    Benichou, S
    Richard, V
    Thomas, D
    Strebel, K
    Benarous, R
    [J]. MOLECULAR CELL, 1998, 1 (04) : 565 - 574
  • [14] Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
    Mariani, R
    Chen, D
    Schröfelbauer, B
    Navarro, F
    König, R
    Bollman, B
    Münk, C
    Nymark-McMahon, H
    Landau, NR
    [J]. CELL, 2003, 114 (01) : 21 - 31
  • [15] Role of ESCRT-I in retroviral budding
    Martin-Serrano, J
    Zang, T
    Bieniasz, PD
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (08) : 4794 - 4804
  • [16] Mechanisms underlying ubiquitination
    Pickart, CM
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 503 - 533
  • [17] TRANSCRIPTION-DEPENDENT AND TRANSCRIPTION-INDEPENDENT NUCLEAR TRANSPORT OF HNRNP PROTEINS
    PINOLROMA, S
    DREYFUSS, G
    [J]. SCIENCE, 1991, 253 (5017) : 312 - 314
  • [18] Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
    Sheehy, AM
    Gaddis, NC
    Choi, JD
    Malim, MH
    [J]. NATURE, 2002, 418 (6898) : 646 - 650
  • [19] Mutational analysis of the human immunodeficiency virus type 1 Vif protein
    Simon, JHM
    Sheehy, AM
    Carpenter, EA
    Fouchier, RAM
    Malim, MH
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (04) : 2675 - 2681
  • [20] COMPLEMENTATION OF VIF-DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY PRIMATE, BUT NOT NONPRIMATE, LENTIVIRUS VIF GENES
    SIMON, JHM
    SOUTHERLING, TE
    PETERSON, JC
    MEYER, BE
    MALIM, MH
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (07) : 4166 - 4172